Evaluation of reproductive function in women treated for bipolar disorder compared to healthy controls

Bipolar Disorders

Volumn 16, Issue 1, 2014, Pages 37-47

  Reynolds May, Margaret F ^a   Kenna, Heather A ^a   Marsh, Wendy ^b   Stemmle, Pascale G ^a   Wang, Po ^a   Ketter, Terence A ^a   Rasgon, Natalie L ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Bipolar disorder; Eating disorder; Hormones; Menstrual abnormalities; Polycystic ovary syndrome; Reproductive function; Women

Indexed keywords

CARBAMAZEPINE; ESTRADIOL; ESTRONE; FOLLITROPIN; HYDROXYPROGESTERONE; LAMOTRIGINE; LITHIUM; LUTEINIZING HORMONE; OXCARBAZEPINE; PRASTERONE; PROGESTERONE; PROLACTIN; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; VALPROIC ACID;

ADULT; AMENORRHEA; ANOREXIA NERVOSA; ARTICLE; BIPOLAR I DISORDER; BIPOLAR II DISORDER; BULIMIA; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEMOGRAPHY; FEMALE; FOLLICULAR PHASE; HUMAN; LONGITUDINAL STUDY; LUTEAL PHASE; MAJOR CLINICAL STUDY; MEDICAL HISTORY; MENSTRUATION DISORDER; MIDDLE AGED; OLIGOMENORRHEA; OVULATION; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; PROSPECTIVE STUDY; REPRODUCTION; REPRODUCTIVE HEALTH; SELF REPORT; TREATMENT DURATION; YOUNG ADULT;

BIPOLAR DISORDER; EATING DISORDER; HORMONES; MENSTRUAL ABNORMALITIES; POLYCYSTIC OVARY SYNDROME; REPRODUCTIVE FUNCTION; WOMEN;

ADOLESCENT; ADULT; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; FEMALE; HUMANS; MENSTRUATION DISTURBANCES; MIDDLE AGED; REPRODUCTIVE PHYSIOLOGICAL PHENOMENA; VALPROIC ACID; YOUNG ADULT;

EID: 84893057659     PISSN: 13985647     EISSN: 13995618     Source Type: Journal    
DOI: 10.1111/bdi.12149     Document Type: Article

References (49)

1. Isojärvi JIT, Laatikainen TJ, Pakarinen AJ, Juntunen KTS, Myllylä VV. Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy. N Engl J Med 1993; 329: 1383-1388.
2. Isojärvi JIT, Laatikainen TJ, Knip M, Pakarinen AJ, Juntunen KT, Myllylä VV. Obesity and endocrine disorders in women taking valproate for epilepsy. Ann Neurol 1996; 39: 579-584.
3. Morrell MJ, Isojärvi J, Taylor AE et al. Higher androgens and weight gain with valproate compared with lamotrigine for epilepsy. Epilepsy Res 2003; 54: 189-199.
4. McIntyre RS, Mancini DA, McCann S, Srinivasan J, Kennedy SH. Valproate, bipolar disorder and polycystic ovarian syndrome. Bipolar Disord 2003; 5: 28-35.
5. O'Donovan C, Kusumakar V, Graves GR, Bird DC. Menstrual abnormalities and polycystic ovary syndrome in women taking valproate for bipolar mood disorder. J Clin Psychiatry 2002; 63: 322-330.
6. Rasgon N. The relationship between polycystic ovary syndrome and antiepileptic drugs: a review of the evidence. J Clin Psychopharmacol 2004; 24: 322-334.
7. Dunaif A, Thomas A. Current concepts in the polycystic ovary syndrome. Annu Rev Med 2001; 52: 401-419.
8. Bilo L, Meo R, Valentino R, Di Carlo C, Striano S, Nappi C. Characterization of reproductive endocrine disorders in women with epilepsy. J Clin Endocrinol Metab 2001; 86: 2950-2956.
9. Bauer J, Jarre A, Klingmüller D, Elger CE. Polycystic ovary syndrome in patients with focal epilepsy: a study in 93 women. Epilepsy Res 2000; 41: 163-167.
10. Murialdo G, Galimberti CA, Magri F et al. Menstrual cycle and ovary alterations in women with epilepsy on antiepileptic therapy. J Endocrinol Invest 1997; 20: 519-526.
11. Rasgon NL, Altshuler LL, Gudeman D et al. Medication status and polycystic ovary syndrome in women with bipolar disorder: a preliminary report. J Clin Psychiatry 2000; 61: 173-178.
12. Altshuler LL, Rasgon N, Elman S et al. Reproductive Endocrine Function in Women Treated for Bipolar Disorder: Reproductive Hormone Levels. New York, NY: American Psychiatric Association, 2004.
13. Bilo L, Meo R. Polycystic ovary syndrome in women using valproate: a review. Gynecol Endocrinol 2008; 24: 562-570.
14. Bauer J, Cooper-Mahkorn D. Reproductive dysfunction in women with epilepsy: menstrual cycle abnormalities, fertility, and polycystic ovary syndrome. Int Rev Neurobiol 2008; 83: 135-155.
15. Newberg AR, Catapano LA, Zarate CA, Manji HK. Neurobiology of bipolar disorder. Expert Rev Neurother 2008; 8: 93-110.
16. Allison DB, Mentore JL, Heo M et al. Antipsychotic-induced weight gain: a comprehensive research synthesis. Am J Psychiatry 1999; 156: 1686-1696.
17. Haddad P. Weight change with atypical antipsychotics in the treatment of schizophrenia. J Psychopharmacol 2005; 19 (Suppl. 6): 16-27.
18. Newcomer JW. Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review. CNS Drugs 2005; 19 (Suppl. 1): 1-93.
19. Franks S. Polycystic ovary syndrome. N Engl J Med 1995; 333: 853-861.
20. Diamanti-Kandarakis E, Kouli CR, Bergiele AT et al. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. J Clin Endocrinol Metab 1999; 84: 4006-4011.
21. Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR, Azziz R. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab 1998; 83: 3078-3082.
22. Wild RA, Carmina E, Diamanti-Kandarakis E et al. Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society. J Clin Endocrinol Metab 2010; 95: 2038-2049.
23. Moran LJ, Misso ML, Wild RA, Norman RJ. Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update 2010; 16: 347-363.
24. Rasgon NL, Kenna HA, Reynolds-May MF et al. Metabolic dysfunction in women with bipolar disorder: the potential influence of family history of type 2 diabetes mellitus. Bipolar Disord 2010; 12: 504-513.
25. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004; 19: 41-47.
26. Azziz R. Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: the Rotterdam criteria are premature. J Clin Endocrinol Metab 2006; 91: 781-785.
27. Franks S. Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: in defense of the Rotterdam criteria. J Clin Endocrinol Metab 2006; 91: 786-789.
28. Barth JH, Yasmin E, Balen AH. The diagnosis of polycystic ovary syndrome: the criteria are insufficiently robust for clinical research. Clin Endocrinol 2007; 67: 811-815.
29. Belosi C, Selvaggi L, Apa R et al. Is the PCOS diagnosis solved by ESHRE/ASRM 2003 consensus or could it include ultrasound examination of the ovarian stroma? Hum Reprod 2006; 21: 3108-3115.
30. Azziz R, Carmina E, Dewailly D et al. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab 2006; 91: 4237-4245.
31. Rasgon NL, Altshuler LL, Fairbanks L et al. Reproductive function and risk for PCOS in women treated for bipolar disorder. Bipolar Disord 2005; 7: 246-259.
32. Rasgon NL, Reynolds MF, Elman S et al. Longitudinal evaluation of reproductive function in women treated for bipolar disorder. J Affect Disord 2005; 89: 217-225.
33. Rasgon N, Bauer M, Glenn T, Elman S, Whybrow PC. Menstrual cycle related mood changes in women with bipolar disorder. Bipolar Disord 2003; 5: 48-52.
34. Akdeniz F, Taneli F, Noyan A, Yüncu Z, Vahip S. Valproate-associated reproductive and metabolic abnormalities: are epileptic women at greater risk than bipolar women? Prog Neuropsychopharmacol Biol Psychiatry 2003; 27: 115-121.
35. Montgomery S, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979; 134: 382-389.
36. Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978; 133: 429-435.
37. Ferriman D, Gallwey JD. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab 1961; 21: 1440-1447.
38. Fornaro M, Perugi G, Gabrielli F et al. Lifetime co-morbidity with different subtypes of eating disorders in 148 females with bipolar disorders. J Affect Disord 2010; 121: 147-151.
39. Wildes JE, Marcus MD, Fagiolini A. Prevalence and correlates of eating disorder co-morbidity in patients with bipolar disorder. Psychiatry Res 2008; 161: 51-58.
40. McElroy SL, Kotwal R, Keck PE Jr. Comorbidity of eating disorders with bipolar disorder and treatment implications. Bipolar Disord 2006; 8: 686-695.
41. McElroy SL, Frye MA, Hellemann G et al. Prevalence and correlates of eating disorders in 875 patients with bipolar disorder. J Affect Disord 2011; 128: 191-198.
42. Baldassano CF, Marangell LB, Gyulai L et al. Gender differences in bipolar disorder: retrospective data from the first 500 STEP-BD participants. Bipolar Disord 2005; 7: 465-470.
43. Kaye WH, Wagner A, Fudge JL, Paulus M. Neurocircuity of eating disorders. Curr Top Behav Neurosci 2011; 6: 37-57.
44. Genazzani AD. Neuroendocrine aspects of amenorrhea related to stress. Pediatr Endocrinol Rev 2005; 2: 661-668.
45. Azziz R, Black V, Hines GA, Fox LM, Boots LR. Adrenal androgen excess in the polycystic ovary syndrome: sensitivity and responsivity of the hypothalamic-pituitary-adrenal axis. J Clin Endocrinol Metab 1998; 83: 2317-2323.
46. Joffe H, Hayes FJ. Menstrual cycle dysfunction associated with neurologic and psychiatric disorders: their treatment in adolescents. Ann N Y Acad Sci 2008; 1135: 219-229.
47. Kogan JN, Otto MW, Bauer MS et al. Demographic and diagnostic characteristics of the first 1000 patients enrolled in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Bipolar Disord 2004; 6: 460-469.
48. Hendrick V, Altshuler LL, Gitlin MJ, Delrahim S, Hammen C. Gender and bipolar illness. J Clin Psychiatry 2000; 61: 393-396.
49. Roy-Byrne P, Post RM, Uhde TW, Porcu T, Davis D. The longitudinal course of recurrent affective illness: life chart data from research patients at the NIMH. Acta Psychiatr Scand Suppl 1985; 317: 1-34.